| Description | Ioforminol, also known as GE-145 and AN-113111, is a new low-osmolar dimeric radiographic contrast agent. GE-145 exhibits similar preclinical properties to other dimeric radiographic contrast media. In addition, the low osmolality enables an iso-osmolar formulation containing a significantly higher concentration of electrolytes than Visipaque. |
| Synonyms | GE-145, GE145, AN 113111, AN113111, AN-113111, GE 145 |
| molecular weight | 1522.13 |
| Molecular formula | C33H40I6N6O15 |
| CAS | 1095110-48-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Wistrand LG, Rogstad A, Hagelin G, Roed L, Oulie I, Gram A, Evans P, Rasmussen H, Grant D, Iveson P, Newton B, Thaning M. GE-145, a new low-osmolar dimeric radiographic contrast medium. Acta Radiol. 2010 Nov;51(9):1014-20. doi: 10.3109/02841851.2010.509739. PubMed PMID: 20849319. 2. Chai CM, Rasmussen H, Eriksen M, Hvoslef AM, Evans P, Newton BB, Videm S. Predicting cardiotoxicity propensity of the novel iodinated contrast medium GE-145: Ventricular fibrillation during left coronary arteriography in pigs. Acta Radiol. 2010 Nov;51(9):1007-13. doi: 10.3109/02841851.2010.504743. PubMed PMID: 20799918. |